Markets.com Logo

APVO

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    1.9654$
  • Previous Close
    2.0646$
  • 52 Week Change
    379.38$
  • Day Range
    -0.10$
  • 52 Week High/Low
    1.7197$ - 381.1$
  • Dividend Per Share
    --
  • Market cap
    6 444 K$
  • EPS
    -8.4
  • Beta
    5.634
  • Volume
    --

About

APVO.US refers to the common stock of Aprea Therapeutics, Inc. Aprea Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate tumor suppressor protein p53. The company is headquartered in Waltham, Massachusetts.
NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

Frances Wang|--
Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Frances Wang|--
RGTI stock crashed 7% today: what’s happening with Rigetti Computing?

RGTI stock crashed 7% today: what’s happening with Rigetti Computing?

Frances Wang|--
Gold price analysis: XAU/USD price today, how high will gold go in 2026?

Gold price analysis: XAU/USD price today, how high will gold go in 2026?

Frances Wang|--
Technology stock to watch in 2026: What is the new NVDA stock price target?

Technology stock to watch in 2026: What is the new NVDA stock price target?

Frances Wang|--
BMNR stock up 9% today: what’s going on with BitMine Immersion Technologies?

BMNR stock up 9% today: what’s going on with BitMine Immersion Technologies?

Frances Wang|--
Solana (SOL) price analysis: What will SOL/USD be worth in 2026?

Solana (SOL) price analysis: What will SOL/USD be worth in 2026?

Frances Wang|--

Factors

APVO.US Stock Price Influencers Company Performance: Positive earnings reports, revenue growth, and successful clinical trial outcomes typically boost the stock price.

Industry Trends: General sentiment toward the biotechnology sector and the performance of peer companies can impact investor confidence.

Regulatory Approvals: FDA approvals or rejections of APVO's drug candidates are major catalysts for price fluctuations.

Market Conditions: Overall market sentiment, economic indicators, and interest rate changes can affect investor risk appetite.

News and Events: Press releases, media coverage, and announcements related to partnerships, acquisitions, or funding rounds can move the stock.

Competition: The emergence of competing therapies or technologies can negatively affect the perceived value of APVO's products.

Investor Sentiment: Social media chatter, online forums, and analyst ratings can influence short-term trading activity.

Clinical Trial Data: Positive clinical trial results often lead to increased investor interest, while negative data can cause a decline.

Financial Health: APVO's cash position, debt levels, and ability to fund research and development influence investor confidence.

Management Team: Changes in leadership or significant strategic decisions by the management team can impact the stock price.

People Also Watch

Latest news

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee|--

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Noah Lee|--

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Liam James|--

Latest Education Articles

A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

Ghko B|--
Contracts for Difference explained: What is CFD trading, how do CFDs work?

Contracts for Difference explained: What is CFD trading, how do CFDs work?

Ghko B|--
Financial market for beginners: How financial markets work, how to invest?

Financial market for beginners: How financial markets work, how to invest?

Ghko B|--